Patent details
EP2170333 Title: RANOLAZINE FOR ELEVATED BRAIN-TYPE NATRIURETIC PEPTIDE
Basic Information
- Publication number:
- EP2170333
- PCT Application Number:
- PCT/US/2008/058063
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP087327763
- PCT Publication Number:
- WO/2008/150565
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- RANOLAZINE FOR ELEVATED BRAIN-TYPE NATRIURETIC PEPTIDE
- French Title of Invention:
- UTILISATION DE RANOLAZINE POUR PEPTIDE CÉRÉBRAL NATRIURÉTIQUE ÉLEVÉ
- German Title of Invention:
- RANOLAZIN FÜR ERHÖHTES NATRIURETISCHES PEPTID VOM GEHIRN-TYP
- SPC Number:
Dates
- Filing date:
- 24/03/2008
- Grant date:
- 20/02/2013
- EP Publication Date:
- 20/02/2013
- PCT Publication Date:
- 11/12/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/04/2010
- EP B1 Publication Date:
- 20/02/2013
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 24/03/2013
- Expiration date:
- 24/03/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 24/03/2008
- Name:
- Gilead Sciences Inc.
- Address:
- 333 Lakeside Drive, Foster City, CA 94404, United States (US)
Inventor
1
- Name:
- BLACKBURN Brent
- Address:
- United States (US)
2
- Name:
- WOLFF Andrew
- Address:
- United States (US)
3
- Name:
- JERLING Marcus
- Address:
- Sweden (SE)
Priority
- Priority Number:
- 941210 P
- Priority Date:
- 31/05/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/495;
| Filing date | Document type | Number of pages |
|---|